Lynx1 Capital Management LP
Top Portfolio Positions
22 positions ·
$632,594,991 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,763,673 | $155,105,192 | 24.52% | |
| GHRS |
GH Research PLC
Healthcare
|
10,763,288 | $151,331,829 | 23.92% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
8,963,500 | $127,371,335 | 20.13% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
2,611,568 | $88,349,345 | 13.97% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
1,880,303 | $36,101,817 | 5.71% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
6,998,902 | $18,407,112 | 2.91% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
1,538,296 | $17,413,510 | 2.75% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
8,019,148 | $8,099,339 | 1.28% | |
| XNCR |
Xencor Inc
Healthcare
|
536,398 | $6,468,959 | 1.02% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
985,113 | $5,418,121 | 0.86% |
Portfolio Trend
18 quarters · across all stocks
Holdings in IBIO
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $129,344 | 68,076 | Shares | Other | 2026-05-04 | |
| 2025-12-31 | $0 | 0 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $876,394 | 1,055,897 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $1,169,315 | 1,538,573 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,466,361 | 862,279 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,112,583 | 862,279 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,914,259 | 862,279 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,266,000 | 600,000 | Shares | Other | 2024-08-19 | |
| 2024-03-31 | $2,436,000 | 600,000 | Shares | Other | 2024-05-30 | |
| No 13F history on record for this holder in this stock. | ||||||